Investigation Launched by Pomerantz Law Firm for Pharming Group N.V. Investors Pomerantz Law Firm is investigating potential unlawful practices involving Pharming Group N.V. due to recent FDA findings impacting its new drug application.

Investigation Launched by Pomerantz Law Firm for Pharming Group N.V. Investors #USA #New_York #Pomerantz_LLP #Pharming_Group #Joenja

New drug offers potential cure for ultra rare inherited condition A teenage patient who helped discover a rare condition is the first to benefit from a new treatment.

#rarediseases #ultrararediseases #immunology #Joenja #leniolisib #PharmingTechnologies #raredisease #ActivatedPI3kinaseDeltaSyndrome #APDS #UniversityofCambridge #Addenbrookes #AnitaChandra #disregulatedimmunesystem #APDSpatients #SpecialisedCommissioning
www.bbc.co.uk/news/article...

First drug for rare disease APDS cleared for NHS use Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat APDS, an ultra-rare immunodeficiency disorder.

NEWS: #Pharming's #Joenja has become the first disease-modifying drug that can be used by the #NHS to treat activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (#APDS), an ultra-rare immunodeficiency disorder. #raredisease